ArticleScientific reports2025
A questionnaire survey of cervical and breast cancer screening among female employees and employees' spouses.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Cancer screening uptake among refugees in high and middle-income countries: a systematic review.Preventive medicine · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
In Japan, cancer screening is conducted under a variety of umbrellas, i.e., via population-based screening, occupational health checkups, insured medical care, and personal medical checkups. Quality control assessment of cancer screenings is conducted by national and local governments only for population-based screenings. The purpose of this study was to clarify the status of women receiving cervical and breast cancer screenings in Japan by any of these means. As a model associated with occupational screenings, we surveyed female employees and male employees' spouses of Sunstar, Inc., a Japanese subsidiary of an international corporation. The number of valid responses collected from March to July 2023 was 345. Among those who had cancer screening either regularly or irregularly, 66% (89/134) and 56% (47/84), respectively, received cervical and breast cancer screenings more frequently than every two years, the prescribed interval for population-based screening. Our survey revealed that a small number of women are routinely receiving cervical and breast cancer screenings more frequently than appropriate, suggesting a need to provide better information to screening consumers and providers on what constitutes appropriate screening schedules. Our survey also revealed that there is no governmental management entity for opportunistic screenings, so the status among female employees and male employee's spouses of a company, Sunstar, Inc. is unclear.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.